Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Research Council grant · Running

deepHelix deepHelix: a massively scalable, AI-powered peptide drug discovery platform

Coordinator
Fundacio Centre De Regulacio Genomica, Spain
Runs
1 March 2025 to 31 August 2026
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101213167

What the project is doing

In the project's own words, from its summary on CORDIS.

Peptide drugs potentially address limitations of both small molecules and antibodies. Small molecules struggle to target protein-protein interactions (PPIs), while antibodies cannot access intracellular proteins. In this project we will develop an AI-driven experimental platform to produce cell-permeable therapeutic peptides made entirely of natural amino acids. The platform will allow the rapid discovery of cost-effective, stable, cell-permeable, and high-affinity peptide binders for use as research tools, in diagnostics, and as therapeutics against intracellular proteins previously considered undruggable targets.

Topics

Who is involved

OrganisationCityCountryRole
Fundacio Centre De Regulacio GenomicaBarcelonaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI